Pathogenetic mechanisms of ischemic stroke: from verification to secondary prevention
Ischemic stroke is an extremely heterogeneous disease: there are more than 200 causes of cerebral catastrophe. Early identification of the pathogenetic mechanism (subtype) of ischemic stroke allows planning an individual secondary prevention strategy, which includes a wide range of pharmaceutical an...
Saved in:
Main Authors: | Aleksey A. Kulesh (Author), Dmitrii A. Demin (Author), Oleg I. Vinogradov (Author) |
---|---|
Format: | Book |
Published: |
ZAO "Consilium Medicum",
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Difficult questions of intravenous thrombolytic therapy in ischemic stroke
by: Aleksey A. Kulesh
Published: (2021) -
Exploring the mechanisms under Zuogui Pill's treatment of ischemic stroke through network pharmacology and in vitro experimental verification
by: Li Li, et al.
Published: (2023) -
Factors Affecting Non-Adherence to Secondary Stroke Prevention Therapy in Ischemic Stroke Patients
by: Zakky Cholisoh, et al.
Published: (2018) -
Personalized approach to diagnosis verification and pathogenetic therapy in benign breast diseases (literature review)
by: Tatyana Yu. Pestrikova, et al.
Published: (2023) -
STATINS IN PREVENTION OF ISCHEMIC STROKE
by: A. V. Susekov, et al.
Published: (2015)